EMBI News and Press, Emerald Bioscience Inc

San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...

San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...

San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with si...

Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th Company executives will share vision and answer audience questions at VirtualInvestorConfer...

Emerald Bioscience ([[EMBI]] +0.6%) has changed its name to Skye Bioscience and will trade under its new ticker symbol, 'SKYE' on the OTC effective On Jan.19, at market open. For further details see: Emerald Bioscience changes name, ticker symbol

San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“EMBI” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma...

Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing Canada NewsWire Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , ...

Live Investor Conference & Webinar: Cannabis Industry Companies Present January 7th Live Investor Conference & Webinar: Cannabis Industry Companies Present January 7th Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com ...

The cannabis industry has sold off significantly over the past 12-18 months, leaving some stocks significantly undervalued on a book/price metric. Cannabis stocks are starting to push upwards again as some companies near profitability and certain metrics will provide information for i...

Emerald Bioscience ([[EMBI]] -0.3%) has announced that its THC prodrug, THCVHS, optimized through a nanoemulsion formulation (THCVHS-NE) in animal models, demonstrated significantly better reduction of intraocular pressure ((IOP)) compared to the commercially approved standard of ca...